Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 285
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04775121 | Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia | ||
| NCT00936156 | Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years | ||
| NCT04940325 | Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer | ||
| NCT00180882 | LMBA02 Protocol for Patients With a Burkitt Lymphoma | ||
| NCT04779151 | Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab | ||
| NCT06116578 | Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab | ||
| NCT01677884 | Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy | ||
| NCT02008734 | Randomized Phase II Study to Assess PD 0332991 in Breast Cancer | ||
| NCT07131163 | Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection | ||
| NCT01566019 | Molecular Screening for Cancer Treatment Optimization | ||
| NCT03244956 | Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer | ||
| NCT00162656 | Treatment of Mature B-cell Lymphoma/Leukaemia | ||
| NCT03596281 | Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer | ||
| NCT03406247 | Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma | ||
| NCT04953312 | Calprotectin, a Biomarker of COVID-19 Severity (CALPRO) | ||
| NCT05830084 | Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma | ||
| NCT06712472 | Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer | ||
| NCT02063009 | Measurement of Cardiac Index Using an Implanted Central Venous Access Port in Patients Scheduled for Oncologic High-risk Surgery | ||
| NCT02025881 | Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma | ||
| NCT04341207 | Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients | ||
| NCT00412503 | Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents | ||
| NCT02369757 | Patients Navigator for Organized Colorectal Cancer Screening | ||
| NCT05267912 | Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers | ||
| NCT00935675 | Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment | ||
| NCT00180934 | Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area | ||
| NCT02679963 | Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer | ||
| NCT02151214 | Efficacy of Parenteral Nutrition in Patients at the Palliative Phase of Cancer. | ||
| NCT02992912 | Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours | ||
| NCT00180830 | Glivec Phase II Pediatric Study | ||
| NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | ||
| NCT07082452 | A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction | ||
| NCT02230176 | Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II | ||
| NCT01960751 | Long Term Neurocognitive Effects of Low-dose Radiation in the Brain: Study of 150 Patients in the French Hemangioma Cohort | ||
| NCT01540058 | Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP | ||
| NCT00181038 | Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery | ||
| NCT00162721 | The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas | ||
| NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | ||
| NCT01516567 | Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation | ||
| NCT00127595 | Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract | ||
| NCT05947903 | Validation of the European Oncology Quality of Life Toolkit | ||
| NCT04746729 | Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy | ||
| NCT02619565 | Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes | ||
| NCT02517281 | Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies | ||
| NCT02390934 | Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer | ||
| NCT06787118 | Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer | ||
| NCT02856425 | Trial Of Pembrolizumab And Nintedanib | ||
| NCT03612791 | Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab | ||
| NCT06642844 | Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment | ||
| NCT07303387 | Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. | ||
| NCT02220049 | Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors |
